On November 8 and 9, Miami, Florida will host Wonderland: Miami, the largest-ever business gathering in the psychedelic medicine sector, presented by Microdose, a guide to the business of psychedelics. Wonderland: Miami will be held at the Adrienne Arsht Center for the Performing Arts in Downtown Miami, Florida.
Wonderland: Miami features 30 programming tracks, panels, fireside chats, networking, a Dragon’s Den style pitch competition and insights from speakers such as Rick Doblin, Ph.D, Founder and Executive Director of Multidisciplinary Association for Psychedelic Studies (MAPS), who will share insights, information and experiences.
Also speaking will be Robin Carhart-Harris, a psychologist and neuroscientist and Head of the Centre for Psychedelic Research, Division of Brain Sciences, Faculty of Medicine at Imperial College London. Carhart-Harris coordinated the first clinical study of psilocybin in the UK and the first clinical study of a classic psychedelic drug in the UK for over 40 years. He’ll be joined by Dr. Joseph Tucker, CEO of what is now Enveric, an innovative biotechnology company developing a next-generation mental health and oncology treatment clinical discovery platform, leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body.
Read More
Wonderland: Miami Takes Shape as the Largest Psychedelic Medicine Business Event
Gymnopilus. by Bernard Spragg. NZ is licensed under CC0 1.0